# A Study of the Pharmacokinetics and Pharmacodynamics of MK1809 (1809-001)(COMPLETED)

> **NCT01033318** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 30 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** MK1809
- **DRUG:** Comparator: Losartan
- **DRUG:** Comparator: Placebo

## Key facts

- **NCT ID:** NCT01033318
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09-11
- **Primary completion:** 2008-06-19
- **Final completion:** 2008-06-19
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01033318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01033318, "A Study of the Pharmacokinetics and Pharmacodynamics of MK1809 (1809-001)(COMPLETED)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01033318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*